World leading Pfizer study on dialysis patients
The first study of its kind in the world, conducted at Laniado Hospital, examined the effectiveness of Pfizer vaccines on dialysis patients. The study was published in the most respected medical journal in the field - Clinical Journal of the American Society of Nephrology – CJASN Dr. Moshe Shasher, Director of the Department of Nephrology at Laniado Hospital, published the first study of its kind in the world examining the level of antibodies that dialysis patients develop after receiving Pfizer vaccines.
The study was published in one of the most important nephrology journals in the world: the Clinical Journal of the American Society of Nephrology - CJASN. Dr. Shasher examined the levels of antibodies developed by 56 dialysis patients at Laniado Hospital, compared with 96 hospital staff - all vaccinated with two vaccine doses. The test was done at least a week after the second vaccine dose. The findings of the study clearly show that dialysis patients develop antibodies at a lower level than the control group of hospital staff.
The significance of the study is now being examined, to find out if it is necessary to change the timing or dosage of the vaccine for dialysis patients to increase their response to the vaccine. Dr. Shasher said that the study was conducted during January and February. As someone who treats dialysis patients daily, he believes we must continue to investigate to ensure that the protection given to our patients from the vaccines is adequate. “My team and I are currently exploring options for further research, to reach practical conclusions and recommendations in the near future”. "The fact that a nephrological journal as important as the Clinical Journal of the American Society of Nephrology chose to publish the article, is a certificate of honour to the hospital staff who engaged in intensive research, at the highest standards." Mr. Nadav Chen, CEO of Laniado, congratulated Dr. Shasher and his team on the impressive achievement.
He said: “The research at Laniado Hospital is a daily activity aimed at achieving abilities and insights to improve the professional care of patients. This study joins other studies in various clinical disciplines published in the most important clinical platforms in the world”.
Kol Yedidenu newsletter June 2021